Sunday, March 15, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
No Result
View All Result

Healthcare investors will double down on key digital health markets

Daily Remedy by Daily Remedy
December 24, 2021
in
0

Digital health investment had a blockbuster year in 2021, propelled in large part by the shift to virtual care during the COVID-19 pandemic.

The first nine months alone brought in a total of $21.3 billion for digital health startups across 541 investment deals, dwarfing the $14.6 billion record of 2020, according to Rock Health, a venture fund dedicated to digital health.

That momentum is projected to continue in 2022 as digital health companies lead the way in healthcare innovation with the use of artificial intelligence, machine learning, data analytics and telehealth.

Source: Fierce Healthcare

https://www.fiercehealthcare.com/digital-health/2022-forecast-investors-will-double-down-these-hot-digital-health-markets

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

In this episode of the Daily Remedy Podcast, Tiffany Ryder discusses her insights on healthcare messaging, the impact of COVID-19 on patient trust, and the importance of transparency in health policy. She emphasizes the need for clear communication in the face of divisiveness and explores the complexities surrounding the estrogen debate. Additionally, Tiffany highlights positive developments in health policy and the necessity of effectively conveying these changes to the public. Tiffany Ryder is a political commentator and public health policy thought leader who publishes the Substack newsletter Signal and Noise: https://signalandnoise.online/ Chapters 00:00 Introduction to Healthcare Conversations 02:58 Signal and Noise: Understanding Healthcare Communication 05:56 The Storytelling Problem in Healthcare 08:58 Navigating Political Divisiveness in Health Policy 11:55 The Role of Media in Health Policy 15:03 Bias in Health Reporting 17:56 Estrogen and Health Policy: A Case Study 24:00 Positive Developments in Health Policy 27:03 Looking Ahead: Future of Health Policy 31:49 Communicating Health Policy Effectively
The Impact of COVID-19 on Patient Trust
YouTube Video ujzgl7HDlsw
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

No Result
View All Result

© 2026 Daily Remedy